434.924.3627
Call Us

434.243.3675

Make an Appointment

Use the online form

Neurosciences

Brain Tumors

From glioblastoma multiforme (GBM) to spinal cord tumors, we treat a range of brain tumors.

Since primary brain tumors account for only 1-2% of all cancers, most doctors aren’t very familiar with brain tumors. At UVA, our neuro-oncology doctors only see patients with neuro-oncologic disorders, and they’re up to date on standard and experimental treatments.

Brain tumor diagnosis? Make sure you're getting the best treatment. Get a second opinion

 

 

 

               

                

              

             

 

Questions?

Patients: Ask questions or make an appointment at 434.243.3675

Doctors: Refer a patient by calling 1.800.552.3723.

    

    

     

     

 

 

 

 

 

                        

Google Search Neuro
Home > Services > Brain Tumors | Neuro-oncology

Brain Tumors

Discover how UVA treats a range of brain tumors, from glioblastoma multiforme (GBM) to spinal cord tumors.

Brain Tumors

From glioblastoma multiforme (GBM) to spinal cord tumors, we treat a range of brain tumors.

Since primary brain tumors account for only 1-2% of all cancers, most doctors aren’t very familiar with brain tumors. At UVA, our neuro-oncology doctors only see patients with neuro-oncologic disorders, and they’re up to date on standard and experimental treatments.

Brain tumor diagnosis? Make sure you're getting the best treatment. Get a second opinion

Life-Saving Procedures

Treatment & Innovation

Research

Glioblastoma has a reputation for being the deadliest of brain cancers, a disease that rapidly spreads with no avail until now. UVA’s Benjamin W. Purow, MD, has identified an enzyme that appears to control multiple signaling pathways in glioblastoma cells – an enzyme that can shut down those pathways and potentially help save lives.  

Find out why this research on glioblastoma could potentially help save lives.

Join a Clinical Trial

  • Tumor Vaccine Trial

    Based on promising results from a phase II clinical trial, Celldex has opened a phase III trial of the tumor vaccine rindopepimut (CDX-110) in patients with newly diagnosed glioblastoma. Patients must enroll in the study before beginning radiation and chemotherapy. 

  • Trials for Malignant Tumors

    We have several new clinical trials for patients with malignant brain tumors.

  • Glioma Trial

    UVA, in conjunction with Harvard Medical School, is now offering a new clinical trial for patients with recurrent high-grade glioma (glioblastoma and anaplastic glioma) using a new angiopoietin-neutralizing agent AMG386 with and without bevacizumab (Avastin®).

  • Trial for Gliomas, Glioblastomas

    We are conducting a phase I clinical trial of an anti-angiogenic, anti-endoglin antibody in conjunction with bevacizumab in patients with recurrent anaplastic gliomas and glioblastomas.

Meet the Experts

Excellence: Recognized

  • Drs. James Larner, David Schiff (left) and Mark Shaffrey were all named in the latest edition of America’s Top Doctors; all were also listed in the companion America’s Top Doctors for Cancer.
  • UVA is ranked as one of the top cancer centers in the country by U.S. News & World Report
  • UVA is one of only two National Cancer Institute (NCI)-designated Clinical Cancer Centers in Virginia. To be recognized by the NCI, a center must have a substantial portfolio of cancer research support and a scientific staff recognized for its cancer research skills in a wide array of scientific areas.

A Team Approach to Treating Brain Tumors

  • At UVA, we believe in offering our patients and their families advanced brain tumor treatments within a coordinated, team-based approach that’s dedicated to maximizing quality of life. Our team — which includes surgeons, medical oncologists, pathologists, nurses, social workers, nutritionists and more — meets regularly to discuss each patient’s care plan and improve patient care.

Make an Appointment

Call us at 434.243.3675

or request an appointment online.

Articles, Videos, Podcasts

 

Surviving a Brain Tumor

On the first anniversary of her diagnosis, Michelle Green found herself cancer-free and almost back to normal. She's thankful to the neuro-oncology staff who helped her in her journey through surgery, recovery, treatment and rehab.

Find more patient stories, podcasts and videos.

Join a Clinical Trial

Get access to the latest advanced treatments: Sign up for a clinical trial.